Invention Grant
- Patent Title: Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
-
Application No.: US16748006Application Date: 2020-01-21
-
Publication No.: US11767526B2Publication Date: 2023-09-26
- Inventor: Kavita Praveen , Claudia Schurmann , Lauren Gurski , Tanya Teslovich Dostal , Goncalo Abecasis , Aris Baras , Giovanni Coppola , Carmelo Romano
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Armstrong Teasdale LLP
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N9/22 ; C12Q1/6883 ; C12N15/113 ; C07K14/515 ; A61K31/713 ; A61K48/00 ; A61P27/02 ; A61P27/06
Abstract:
The present disclosure provides methods of treating patients having an ophthalmic condition, methods of identifying subjects having an increased risk of developing an ophthalmic condition, methods of detecting human angiopoietin like 7 (ANGPTL7) variant nucleic acid molecules and variant polypeptides, and ANGPTL7 variant nucleic acid molecules and variant polypeptides.
Public/Granted literature
- US20200231965A1 Treatment Of Ophthalmic Conditions With Angiopoietin-Like 7 (ANGPTL7) Inhibitors Public/Granted day:2020-07-23
Information query
IPC分类:
